INDIUM IN-111 PENTETREOTIDE KIT (indium in-111 pentetreotide) by PharmaIN is clinical pharmacology general pentetreotide is a dtpa conjugate of octreotide, which is a long-acting analog of the human hormone, somatostatin. First approved in 2024.
Drug data last refreshed 1w ago
CLINICAL PHARMACOLOGY General Pentetreotide is a DTPA conjugate of octreotide, which is a long-acting analog of the human hormone, somatostatin. Indium In 111 pentetreotide binds to somatostatin receptors on cell surfaces throughout the body. Within an hour of injection, most of the dose of indium…
Worked on INDIUM IN-111 PENTETREOTIDE KIT at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.